Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Ballet · SciRah

Researcher profile · Semantic Scholar

V. Ballet

Share profile

V. Ballet — researcher profile on SciRah

h-index: 29
Works: 147
Citations: 5,398

Most-cited papers

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
K. Machiels, M. Joossens, J. Sabino, V. De Preter +10 more
2013Gut1,768 citations
Semantic Scholar
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
Niels Vande Casteele, M. Ferrante, G. Van Assche, V. Ballet +6 more
2015Gastroenterology859 citations
Semantic Scholar
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
J. Sabino, S. Vieira-Silva, K. Machiels, M. Joossens +7 more
2016Gut390 citations Open access
Semantic Scholar
Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease
T. Lobatón, M. Ferrante, P. Rutgeerts, V. Ballet +2 more
2015Alimentary Pharmacology and Therapeutics181 citations
Semantic Scholar
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease
B. Verstockt, S. Verstockt, J. Dehairs, V. Ballet +6 more
2019EBioMedicine141 citations Open access
Semantic Scholar
Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial
R. Bisschops, T. Bessissow, J. Joseph, F. Baert +9 more
2017Gut134 citations Open access
Semantic Scholar
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.
D. Drobne, P. Bossuyt, C. Breynaert, T. Cattaert +12 more
2015Clinical Gastroenterology and Hepatology131 citations
Semantic Scholar
Metabolic Profiling of the Impact of Oligofructose-Enriched Inulin in Crohn's Disease Patients: A Double-Blinded Randomized Controlled Trial
V. De Preter, M. Joossens, V. Ballet, Z. Shkedy +3 more
2013Clinical and Translational Gastroenterology88 citations Open access
Semantic Scholar
Characteristics of Skin Lesions Associated With AntiTumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
I. Cleynen, W. van Moerkercke, T. Billiet, P. Vandecandelaere +11 more
2016Annals of Internal Medicine76 citations
Semantic Scholar
Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience
T. Billiet, I. Cleynen, V. Ballet, M. Ferrante +3 more
2016Alimentary Pharmacology and Therapeutics49 citations
Semantic Scholar
Thromboembolism as an important complication of inflammatory bowel disease
L. Bollen, Niels Vande Casteele, V. Ballet, G. Van Assche +3 more
2016European Journal of Gastroenterology and Hepathology47 citations
Semantic Scholar
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn’s disease
T. Billiet, I. Cleynen, V. Ballet, K. Claes +6 more
2017Scandinavian Journal of Gastroenterology46 citations
Semantic Scholar
Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response
E. Dreesen, T. van Stappen, V. Ballet, M. Peeters +7 more
2018Alimentary Pharmacology and Therapeutics43 citations Open access
Semantic Scholar
Identifying predictors of low adherence in patients with inflammatory bowel disease
S. Coenen, E. Weyts, V. Ballet, M. Noman +4 more
2016European Journal of Gastroenterology and Hepathology43 citations
Semantic Scholar
Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease
S. Coenen, E. Weyts, Cedric Jorissen, P. De Munter +5 more
2017Inflammatory Bowel Diseases41 citations
Semantic Scholar
Characteristics of Skin Lesions Associated With Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
I. Cleynen, W. van Moerkercke, T. Billiet, P. Vandecandelaere +11 more
201537 citations
Semantic Scholar
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium
B. Creyns, I. Jacobs, B. Verstockt, J. Cremer +8 more
2020Frontiers in Immunology36 citations Open access
Semantic Scholar
Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease
C. de Bie, V. Ballet, N. Hendriks, S. Coenen +4 more
2015Alimentary Pharmacology and Therapeutics32 citations Open access
Semantic Scholar
PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis
M. Mahler, J. Damoiseaux, V. Ballet, D. Dillaerts +8 more
2017Clinical Chemistry and Laboratory Medicine20 citations Open access
Semantic Scholar
Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered care
S. Coenen, E. Weyts, S. Vermeire, M. Ferrante +4 more
2017European Journal of Gastroenterology and Hepathology18 citations
Semantic Scholar
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients
I. Detrez, Debby Thomas, K. van Steen, V. Ballet +6 more
2019Journal of Clinical Gastroenterology15 citations
Semantic Scholar
P494 Elderly patients with inflammatory bowel disease under anti-TNF therapy: efficacy and safety
T. L. Ortega, S. Vermeire, V. Ballet, P. Rutgeerts +2 more
20148 citations
Semantic Scholar
Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment
L. Wauters, T. Billiet, K. Papamichael, V. Ballet +6 more
2017European Journal of Gastroenterology and Hepathology7 citations
Semantic Scholar
Recent Anti-TNF Exposure Predicts Lower Vedolizumab Trough Concentrations in Patients with Crohn Disease
A. Gils, E. Dreesen, G. Compernolle, M. Peeters +7 more
20176 citations
Semantic Scholar
OP020 Recent anti-TNF exposure predicts lower vedolizumab trough concentrations in patients with Crohn's disease.
A. Gils, E. Dreesen, G. Compernolle, Miet Peeters +7 more
2017Journal of Crohn's & Colitis5 citations
Semantic Scholar
Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
I. Cleynen, Loes Linsen, S. Verstockt, B. Verstockt +7 more
2019Frontiers in Medicine4 citations Open access
Semantic Scholar
Intestinal microbial signature in patients with primary sclerosing cholangitis
J. Sabino, S. Vieira-Silva, K. Machiels, M. Joossens +7 more
20154 citations
Semantic Scholar
Mo1179 Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease
T. L. Ortega, S. Vermeire, V. Ballet, P. Rutgeerts +2 more
20144 citations Open access
Semantic Scholar
O-003 YI Drug Level Versus Clinically Based Dosing of Infliximab Maintenance Therapy In IBD: Final Results of the Randomized Controlled Taxit Trial
Niels Vande Casteele, A. Gils, G. Compernolle, V. Ballet +7 more
20134 citations
Semantic Scholar
Safety of sequential biological therapy in inflammatory bowel disease: results from a tertiary referral centre
A. Moens, Nasim Sadat Seyed Tabib, V. Ballet, J. Sabino +2 more
2022Alimentary Pharmacology and Therapeutics3 citations Open access
Semantic Scholar
Tu1308 Adequate Trough Concentrations and Sustained TNF Suppression Early on During Induction Therapy With Adalimumab Predict Remission in Anti-TNF Naïve Crohn's Disease Patients
N. V. Casteele, D. Mould, A. Gils, S. Tops +6 more
20153 citations
Semantic Scholar
Su1204 Long-Term Outcome of Infliximab Therapy in Patients With Ulcerative Colitis: Identification of Predictors of Relapse-Free and Colectomy-Free Survival
M. Ferrante, M. Arias, S. Vermeire, M. Noman +8 more
20133 citations
Semantic Scholar
P601 Development and validation of dried blood spot sampling as a tool to identify the best time point to measure predictive ustekinumab serum concentrations in patients with Crohn’s disease
N. van den Berghe, B. Verstockt, E. Vandeput, V. Ballet +4 more
20202 citations Open access
Semantic Scholar
P827 Up-regulation of IL17-related pathways in affected colon from ulcerative colitis compared with Crohn’s disease
S. Verstockt, F. V. Donck, B. Verstockt, E. Glorieus +9 more
2019Journal of Crohn's & Colitis2 citations
Semantic Scholar
DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients
B. Creyns, B. Verstockt, J. Cremer, V. Ballet +5 more
2019Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
Intestinal microbial signature predicts postoperative Crohn's disease recurrence following ileocaecal resection with ileocolonic anastomosis
K. Machiels, W. Vanhove, J. Sabino, M. Joossens +11 more
20152 citations Open access
Semantic Scholar
286 Drug Concentrations and Antibodies to Infliximab Are Inferior to the Impact of Disease Burden in Primary Non-Response to Infliximab in Crohn's Disease Patients
T. Billiet, I. Cleynen, V. Ballet, K. Claes +5 more
20152 citations
Semantic Scholar
Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohn's disease patients
T. Billiet, I. Cleynen, V. Ballet, K. Claes +5 more
20152 citations
Semantic Scholar
Mo1880 - Ustekinumab Induces Limited Mucosal Healing after 6 Months in a Real-Life, Prospective Cohort of Patients with Refractory Crohn's Disease
B. Verstockt, M. Noman, Isolde Aerden, M. Peeters +7 more
20181 citations
Semantic Scholar
P704 Ustekinumab induces limited mucosal healing after 6 months in a real-life, prospective cohort of patients with refractory Crohn’s disease
B. Verstockt, M. Noman, Isolde Aerden, M. Peeters +7 more
20181 citations
Semantic Scholar
NO003 IBD nurses as integral part of a multidisciplinary IBD team: prospective study on view on patient outcomes.
S. Coenen, Ellen Weyts, P. Geens, S. Vermeire +5 more
2017Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
DOP050 Serum proteomic analysis defines novel circulating inflammatory markers for Crohn's disease and response to anti-TNF therapy.
H. Korf, J. Sabino, V. Ballet, M. de Bruyn +3 more
2017Journal of Crohn's & Colitis1 citations
Semantic Scholar
Effects of introduction of an inflammatory bowel diseases nurse position on the quality of delivered care
S. Coenen, E. Weyts, S. Vermeire, M. Ferrante +3 more
20161 citations
Semantic Scholar
262 Intestinal Dysbiosis in Patients With Primary Sclerosing Cholangitis
J. Sabino, S. Vieira-Silva, K. Machiels, M. Joossens +7 more
20151 citations
Semantic Scholar
Sa1237 Prediction of Primary Response to Infliximab in Crohn's Disease: A Matrix-Based Prediction Model
T. Billiet, M. de Bruyn, V. Ballet, K. Claes +11 more
20141 citations Open access
Semantic Scholar
Tu1748 Predominant Gut Microbiota Predict Pouchitis Following Colectomy and IPAA in Ulcerative Colitis
K. Machiels, M. Joossens, I. Arijs, I. Terrasson +9 more
20141 citations Open access
Semantic Scholar
P566 A matrix-based prediction model for primary response to infliximab in Crohn's disease patients
T. Billiet, M. de Bruyn, K. Claes, V. Ballet +11 more
20141 citations Open access
Semantic Scholar
P187 MRI T2 relaxometry to image fibrosis in patients with Crohn's disease
C. Breynaert, T. Dresselaers, R. Peeters, I. Roebben +10 more
20141 citations Open access
Semantic Scholar
P311 Intensive dried blood spot sampling shows a higher drug exposure throughout the first 24 weeks of therapy in ustekinumab-treated Crohn’s disease patients achieving endoscopic remission
N. van den Berghe, B. Verstockt, V. Ballet, A. Gils +5 more
20210 citations
Semantic Scholar
Sa1897 DEVELOPMENT AND VALIDATION OF DRIED BLOOD SPOT SAMPLING AS A TOOL TO IDENTIFY THE BEST TIME POINT TO MEASURE PREDICTIVE USTEKINUMAB SERUM CONCENTRATIONS IN PATIENTS WITH CROHN'S DISEASE
Nathalie Van den Berghe, B. Verstockt, Vandeput Eline, V. Ballet +4 more
20200 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ferrante×41
Invite
M. Ferrante — researcher profile on SciRah
S. Vermeire×41
Invite
S. Vermeire — researcher profile on SciRah
G. Van Assche×41
Invite
G. Van Assche — researcher profile on SciRah
A. Gils×17
Invite
A. Gils — researcher profile on SciRah

×16

Invite

P. Rutgeerts — researcher profile on SciRah

Invite

M. Noman — researcher profile on SciRah

B. Verstockt×10

Invite

B. Verstockt — researcher profile on SciRah

Invite

I. Cleynen — researcher profile on SciRah

Invite

T. Billiet — researcher profile on SciRah

Invite

J. Sabino — researcher profile on SciRah

Invite

M. Joossens — researcher profile on SciRah

K. van Steen×7

Invite

K. van Steen — researcher profile on SciRah